News on CFS_Chronic_Fatigue from BioPortfolio.com http://www.BioPortfolio.com Consolidated CFS_Chronic_Fatigue news from BioPortfolio.com Tue, 09 Feb 2010 13:08:57 GMT en Demographic and clinical aspects of an Italian patient population with chronic fatigue syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034403&HITNO=0&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034403&THISHREF=http://c.moreover.com/click/here.pl%3fz2535769871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034403&HITNO=0&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034403&THISHREF=http://c.moreover.com/click/here.pl%3fz2535769871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Whittemore Peterson Institute Announces Renowned Health Expert as New Spokespersonhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033096&HITNO=1&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033096&THISHREF=http://c.moreover.com/click/here.pl%3fz2535007200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033096&HITNO=1&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033096&THISHREF=http://c.moreover.com/click/here.pl%3fz2535007200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Men undergoing radiotherapy for prostate cancer risk chronic fatiguehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030212&HITNO=2&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030212&THISHREF=http://c.moreover.com/click/here.pl%3fz2533499844%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030212&HITNO=2&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030212&THISHREF=http://c.moreover.com/click/here.pl%3fz2533499844%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Academy of Finland: School burnouthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002950&HITNO=3&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002950&THISHREF=http://c.moreover.com/click/here.pl%3fz2519243294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002950&HITNO=3&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002950&THISHREF=http://c.moreover.com/click/here.pl%3fz2519243294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Amphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999539&HITNO=4&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999539&THISHREF=http://c.moreover.com/click/here.pl%3fz2517484556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999539&HITNO=4&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999539&THISHREF=http://c.moreover.com/click/here.pl%3fz2517484556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999564&HITNO=5&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999564&THISHREF=http://c.moreover.com/click/here.pl%3fz2517502792%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999564&HITNO=5&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999564&THISHREF=http://c.moreover.com/click/here.pl%3fz2517502792%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999562&HITNO=6&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999562&THISHREF=http://c.moreover.com/click/here.pl%3fz2517501487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999562&HITNO=6&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999562&THISHREF=http://c.moreover.com/click/here.pl%3fz2517501487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998644&HITNO=7&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998644&THISHREF=http://c.moreover.com/click/here.pl%3fz2517151906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998644&HITNO=7&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998644&THISHREF=http://c.moreover.com/click/here.pl%3fz2517151906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998739&HITNO=8&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998739&THISHREF=http://c.moreover.com/click/here.pl%3fz2517175915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998739&HITNO=8&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998739&THISHREF=http://c.moreover.com/click/here.pl%3fz2517175915%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999117&HITNO=9&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999117&THISHREF=http://c.moreover.com/click/here.pl%3fz2517326902%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999117&HITNO=9&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999117&THISHREF=http://c.moreover.com/click/here.pl%3fz2517326902%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDMN Newswire: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999093&HITNO=10&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999093&THISHREF=http://c.moreover.com/click/here.pl%3fz2517319148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999093&HITNO=10&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999093&THISHREF=http://c.moreover.com/click/here.pl%3fz2517319148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDMN Newswire: Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Amphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998664&HITNO=11&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998664&THISHREF=http://c.moreover.com/click/here.pl%3fz2517156891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998664&HITNO=11&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998664&THISHREF=http://c.moreover.com/click/here.pl%3fz2517156891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Hemispherx Biopharma Receives Favorable Notice Via Itshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998591&HITNO=12&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998591&THISHREF=http://c.moreover.com/click/here.pl%3fz2517137127%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998591&HITNO=12&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998591&THISHREF=http://c.moreover.com/click/here.pl%3fz2517137127%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via MSN Money: Gastric Ulcer Bacteria Turn Immune Defence Inwardshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962906&HITNO=13&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962906&THISHREF=http://c.moreover.com/click/here.pl%3fz2497525423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962906&HITNO=13&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962906&THISHREF=http://c.moreover.com/click/here.pl%3fz2497525423%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by Inves...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956388&HITNO=14&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956388&THISHREF=http://c.moreover.com/click/here.pl%3fz2494530242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956388&HITNO=14&MSIZE=67&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CFS_Chronic_Fatigue&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956388&THISHREF=http://c.moreover.com/click/here.pl%3fz2494530242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: